We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.85B
AUM Growth
-$153M
Cap. Flow
-$306M
Cap. Flow %
-7.96%
Top 10 Hldgs %
17.74%
Holding
705
New
68
Increased
289
Reduced
229
Closed
52

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$22.5M
2
AET
Aetna Inc
AET
+$21.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$20.4M
4
ADI icon
Analog Devices
ADI
+$19.4M
5
CMI icon
Cummins
CMI
+$17.3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$43.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$40.1M
3
ABBV icon
AbbVie
ABBV
+$37.1M
4
GILD icon
Gilead Sciences
GILD
+$24.2M
5
PH icon
Parker-Hannifin
PH
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 24.55%
2 Financials 13.06%
3 Technology 10.24%
4 Consumer Staples 10.19%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPRX
401
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.12M 0.03%
27,000
-9,000
-25% -$391K
COR icon
402
Cencora
COR
$60.3B
$1.1M 0.03%
13,900
-17,875
-56% -$1.43M
GGP
403
DELISTED
GGP Inc.
GGP
$1.1M 0.03%
36,978
-4,140
-10% -$117K
NEM icon
404
Newmont
NEM
$98.2B
$1.09M 0.03%
27,978
+8,249
+42% +$273K
CERN
405
DELISTED
Cerner Corp
CERN
$1.08M 0.03%
18,516
+8,999
+95% +$501K
WAT icon
406
Waters Corp
WAT
$36.8B
$1.08M 0.03%
7,684
+2,463
+47% +$333K
MZOR
407
DELISTED
Mazor Robotics Ltd.
MZOR
$1.08M 0.03%
+60,000
New +$837K
KPTI icon
408
Karyopharm Therapeutics
KPTI
$168M
$1.07M 0.03%
10,667
-1,800
-14% -$234K
ED icon
409
Consolidated Edison
ED
$41.6B
$1.07M 0.03%
13,314
-121,723
-90% -$9.15M
STZ icon
410
Constellation Brands
STZ
$22.2B
$1.06M 0.03%
6,441
+1,502
+30% +$235K
PLD icon
411
Prologis
PLD
$138B
$1.06M 0.03%
21,625
+2,773
+15% +$130K
AMH icon
412
American Homes 4 Rent
AMH
$12B
$1.06M 0.03%
51,750
KTWO
413
DELISTED
K2M Group Holdings, Inc
KTWO
$1.05M 0.03%
68,000
+2,000
+3% +$28.2K
DVAX
414
DELISTED
Dynavax Technologies
DVAX
$1.04M 0.03%
71,500
CFG icon
415
Citizens Financial Group
CFG
$30.4B
$1.04M 0.03%
51,969
-68,601
-57% -$1.52M
SRE icon
416
Sempra
SRE
$60.8B
$1.04M 0.03%
18,202
+3,136
+21% +$166K
MU icon
417
Micron Technology
MU
$1.04T
$1.03M 0.03%
75,054
+5,462
+8% +$62.1K
TGTX icon
418
TG Therapeutics
TGTX
$8.58B
$1.03M 0.03%
170,000
-37,000
-18% -$301K
XLNX
419
DELISTED
Xilinx Inc
XLNX
$1.02M 0.03%
22,115
+2,536
+13% +$116K
TRVN
420
DELISTED
Trevena, Inc.
TRVN
$1.01M 0.03%
256
EQIX icon
421
Equinix
EQIX
$107B
$999K 0.03%
2,577
+644
+33% +$225K
MTD icon
422
Mettler-Toledo International
MTD
$26.8B
$998K 0.03%
2,735
+978
+56% +$357K
KDP icon
423
Keurig Dr Pepper
KDP
$40.4B
$994K 0.03%
10,285
-36,489
-78% -$3.35M
VFC icon
424
VF Corp
VFC
$6.68B
$989K 0.03%
17,087
-4,020
-19% -$238K
K
425
DELISTED
Kellanova
K
$983K 0.03%
12,820
-5,629
-31% -$404K

Similar funds

Candriam SCA's Q2 2016 Portfolio in Review

As of Q2 2016, Candriam SCA held 705 positions worth $3.85B, down 3.8% from $4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $306M in Q2 2016, closing 52 positions and reducing 229 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in NiSource worth $14.5M.

  • Candriam SCA's largest Q2 2016 buy was NiSource: 547,430 shares worth $14.5M.
  • Candriam SCA added most to Abbott in Q2 2016, an estimated $22.5M increase.
  • Candriam SCA's biggest Q2 2016 reduction was Intel, cutting an estimated $43.9M.
  • Candriam SCA fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $9.2M.
  • Candriam SCA's ten largest holdings make up 18% of its $3.85B portfolio in Q2 2016.
  • Candriam SCA opened 68 new positions and closed 52 in Q2 2016.
  • Candriam SCA's portfolio value fell 3.8% quarter-over-quarter to $3.85B.

Based on Candriam SCA's 13F filing for Q2 2016, filed 26 Jul 2016.